Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators.

Saved in:

Bibliographic Details
Title:	Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators.
Authors:	Cimiano P; Semalytix GmbH, Bielefeld, Germany.; CITEC, Bielefeld University, Bielefeld, Germany., Collins B; Boehringer Ingelheim International GmbH, Ingelheim, Germany., De Vuono MC; Chiesi Farmaceutici SpA, Parma, Italy., Escudier T; Pistoia Alliance, Wakefield, MA, United States., Gottowik J; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Hartung M; Semalytix GmbH, Bielefeld, Germany., Leddin M; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Neupane B; Takeda Pharmaceuticals Co., Ltd., Cambridge, MA, United States., Rodriguez-Esteban R; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Schmidt AL; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Starke-Knäusel C; Semalytix GmbH, Bielefeld, Germany., Voorhaar M; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Wieckowski K; SageFiber, Ustron, Poland.
Source:	Frontiers in medicine [Front Med (Lausanne)] 2024 Mar 06; Vol. 11, pp. 1274688. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2296-858X
DOI:	10.3389/fmed.2024.1274688